U.S. judge orders 'Pharma Bro' Martin Shkreli pay back $64M, bars him from drug industry

Martin Shkreli must return $64.6 million US in profits he and his former company reaped from raising the price of the life-saving drug Daraprim, a federal judge ruled Friday while Shkreli from participating in the pharmaceutical industry for the rest of his life.